ELV

SELL

Elevance Health, Inc.

Healthcare · Rank #426 · Analyzed Apr 20, 2026

$323.05

Current Price

$3694.81

Intrinsic Value

0.0%

Upside/Downside

1/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score1/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$160.34

Base (IV)$3694.81

High$5422.44

Entry Points

Conservative$160.34

Moderate$1927.57

Aggressive$3694.81

⚠️ Warnings

Upside capped: raw 1579% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity13.2% → 0.5/1.0

Debt LevelD/E 74 → 0/1.0

Revenue QualityGrowth 12.6%, margin Δ+0.0% → 0.5/1.0

Moat Strength1.0/5 → 0/1.0

Profit Margins2.8% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.